ATE433448T1 - Kondensierte heterocyclen und deren verwendungen - Google Patents

Kondensierte heterocyclen und deren verwendungen

Info

Publication number: ATE433448T1
Authority: AT; Austria
Prior art keywords: condensed heterocycles; heterocycles; condensed
Prior art date: 2003-03-07

Application number

AT04717339T

Other languages

English (en)

Inventor

Brian Aquila

Michael Block

Audrey Davies

Jayachandran Ezhuthachan

Sandra Filla

Richard Luke

Timothy Pontz

Maria-Elena Theoclitou

Xiaolan Zheng

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-03-07

Filing date

2004-03-04

Publication date

2009-06-15

2003-03-07 Priority claimed from SE0300627A external-priority patent/SE0300627D0/xx

2003-04-15 Priority claimed from SE0301138A external-priority patent/SE0301138D0/xx

2003-06-10 Priority claimed from SE0301697A external-priority patent/SE0301697D0/xx

2003-10-24 Priority claimed from SE0302826A external-priority patent/SE0302826D0/xx

2004-03-04 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2009-06-15 Application granted granted Critical

2009-06-15 Publication of ATE433448T1 publication Critical patent/ATE433448T1/de

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Cardiology (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Urology & Nephrology (AREA)
Orthopedic Medicine & Surgery (AREA)
Heart & Thoracic Surgery (AREA)
Ophthalmology & Optometry (AREA)
Vascular Medicine (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Oncology (AREA)
Hematology (AREA)
Transplantation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Plural Heterocyclic Compounds (AREA)

AT04717339T 2003-03-07 2004-03-04 Kondensierte heterocyclen und deren verwendungen ATE433448T1 (de)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
SE0300627A SE0300627D0 (sv)	2003-03-07	2003-03-07	Novel fused heterocycles and uses therof
SE0301138A SE0301138D0 (sv)	2003-04-15	2003-04-15	Novel fused heterocycles and uses thereof
SE0301697A SE0301697D0 (sv)	2003-06-10	2003-06-10	Novel fused heterocycles and uses thereof
SE0302826A SE0302826D0 (sv)	2003-10-24	2003-10-24	Novel fused heterocycles and uses thereof
PCT/SE2004/000304 WO2004078758A1 (en)	2003-03-07	2004-03-04	Novel fused heterocycles and uses thereof

Publications (1)

Publication Number	Publication Date
ATE433448T1 true ATE433448T1 (de)	2009-06-15

Family

ID=32966643

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT04717339T ATE433448T1 (de)	2003-03-07	2004-03-04	Kondensierte heterocyclen und deren verwendungen

Country Status (24)

Country	Link
US (1)	US20060270689A1 (de)
EP (1)	EP1601673B1 (de)
JP (2)	JP3947758B2 (de)
KR (1)	KR20050107784A (de)
AR (1)	AR043487A1 (de)
AT (1)	ATE433448T1 (de)
AU (1)	AU2004218080B2 (de)
BR (1)	BRPI0408150A (de)
CA (1)	CA2518224C (de)
CY (1)	CY1109300T1 (de)
DE (1)	DE602004021477D1 (de)
DK (1)	DK1601673T3 (de)
ES (1)	ES2326647T3 (de)
IS (1)	IS8036A (de)
MX (1)	MXPA05009577A (de)
MY (1)	MY141583A (de)
NO (1)	NO20054340L (de)
NZ (1)	NZ542227A (de)
PL (1)	PL1601673T3 (de)
PT (1)	PT1601673E (de)
SI (1)	SI1601673T1 (de)
TW (1)	TW200510427A (de)
UA (1)	UA81470C2 (de)
WO (1)	WO2004078758A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6545004B1 (en)	1999-10-27	2003-04-08	Cytokinetics, Inc.	Methods and compositions utilizing quinazolinones
US7230000B1 (en)	1999-10-27	2007-06-12	Cytokinetics, Incorporated	Methods and compositions utilizing quinazolinones
AU2003213092A1 (en)	2002-02-15	2003-09-09	Smithkline Beecham Corporation	Syntheses of quinazolinones
WO2003097053A1 (en)	2002-05-09	2003-11-27	Cytokinetics, Inc.	Compounds, compositions, and methods
KR20050036911A (ko)	2002-05-09	2005-04-20	싸이토키네틱스, 인코포레이티드	화합물들, 방법 및 조성물
JP2005536475A (ja)	2002-05-23	2005-12-02	サイトキネティクス・インコーポレーテッド	化合物、組成物、および方法
WO2003106426A1 (en)	2002-06-14	2003-12-24	Cytokinetics, Inc.	Compounds, compositions, and methods
EP1537089A4 (de)	2002-07-23	2008-04-16	Cytokinetics Inc	Verbindungen, zusammenstellungen und verfahren
AU2003277079A1 (en)	2002-09-30	2004-05-04	Cytokinetics, Inc.	Compounds, compositions, and methods
WO2006018628A1 (en) *	2003-03-07	2006-02-23	Astrazeneca Ab	Enantiomers of selected fused pyrimidones and uses in the treatment and preventi on of cancer
US7550590B2 (en) *	2003-03-25	2009-06-23	Takeda Pharmaceutical Company Limited	Dipeptidyl peptidase inhibitors
US7022850B2 (en)	2003-05-22	2006-04-04	Bristol-Myers Squibb Co.	Bicyclicpyrimidones and their use to treat diseases
WO2005061460A1 (en)	2003-12-08	2005-07-07	Cytokinetics, Inc.	Compounds, compositions, and methods
JP2008509977A (ja) *	2004-08-18	2008-04-03	アストラゼネカアクチボラグ	癌の処置及び予防における選択された縮合複素環の鏡像異性体及びその使用
AR050921A1 (es) *	2004-08-18	2006-12-06	Astrazeneca Ab	Heterociclos fusionados seleccionados y usos de los mismos
EP1856128A4 (de) *	2005-01-19	2009-12-23	Merck & Co Inc	Inhibitoren von mitotischem kinesin
DE102005011822A1 (de) *	2005-03-15	2006-09-21	Merck Patent Gmbh	Phthalazinone
DE102005027168A1 (de)	2005-06-13	2006-12-14	Merck Patent Gmbh	Tetrahydrochinoline
PL2170340T3 (pl)	2007-06-21	2016-06-30	Neuronascent Inc	Sposoby i kompozycje stymulacji neurogenezy i hamowania degeneracji neuronów z wykorzystaniem izotiazolopirymidonów
WO2009001214A2 (en) *	2007-06-28	2008-12-31	Pfizer Products Inc.	Thieno[2,3-d]pyrimidin-4(3h)-one, isoxazolo[5,4-d]pyrimidin-4(5h)-one and isothiazolo[5,4-d]pyrimidin-4(5h)-one derivatives as calcium receptor antagonists
CN114478429B (zh) *	2020-11-13	2023-11-17	中国科学院大连化学物理研究所	一种3-烷硫基异噻唑衍生物及其合成方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6545004B1 (en) *	1999-10-27	2003-04-08	Cytokinetics, Inc.	Methods and compositions utilizing quinazolinones
US7230000B1 (en) *	1999-10-27	2007-06-12	Cytokinetics, Incorporated	Methods and compositions utilizing quinazolinones
NZ526622A (en) *	2000-12-11	2006-07-28	Amgen Sf Llc	CXCR3 antagonists
US6809102B2 (en) *	2001-03-29	2004-10-26	Bristol-Myers Squibb Company	Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
WO2003039460A2 (en) *	2001-11-07	2003-05-15	Merck & Co., Inc.	Mitotic kinesin inhibitors
US6753428B2 (en) *	2001-11-20	2004-06-22	Cytokinetics, Inc.	Process for the racemization of chiral quinazolinones
WO2003049679A2 (en) *	2001-12-06	2003-06-19	Merck & Co., Inc.	Mitotic kinesin inhibitors
JP4597519B2 (ja) *	2001-12-06	2010-12-15	メルク・シャープ・エンド・ドーム・コーポレイション	有糸分裂キネシン阻害薬
US20050107404A1 (en) *	2001-12-06	2005-05-19	Fraley Mark E.	Mitotic kinesin inhibitors
AU2002364128B2 (en) *	2001-12-06	2008-03-06	Merck Sharp & Dohme Corp.	Mitotic kinesin inhibitors
WO2003049527A2 (en) *	2001-12-06	2003-06-19	Merck & Co., Inc.	Mitotic kinesin inhibitors
BR0309278A (pt) *	2002-04-17	2005-04-26	Cytokinetics Inc	Composto, composição, métodos para modular a atividade da cinesina ksp, para inibir a ksp, para o tratamento de uma doença proliferativa celular, e, uso de um composto
KR20050036911A (ko) *	2002-05-09	2005-04-20	싸이토키네틱스, 인코포레이티드	화합물들, 방법 및 조성물
WO2003097053A1 (en) *	2002-05-09	2003-11-27	Cytokinetics, Inc.	Compounds, compositions, and methods
JP2005536475A (ja) *	2002-05-23	2005-12-02	サイトキネティクス・インコーポレーテッド	化合物、組成物、および方法
US6949538B2 (en) *	2002-07-17	2005-09-27	Cytokinetics, Inc.	Compounds, compositions, and methods
US7022850B2 (en) *	2003-05-22	2006-04-04	Bristol-Myers Squibb Co.	Bicyclicpyrimidones and their use to treat diseases
US7345046B2 (en) *	2003-05-30	2008-03-18	Chiron Corporation	Heteroaryl-fused pyrimidinyl compounds as anticancer agents
KR20060069356A (ko) *	2003-06-20	2006-06-21	카이론 코포레이션	항암제로서 피리디노[1,2-α]피리미딘-4-온 화합물
EP1670456A2 (de) *	2003-10-06	2006-06-21	Cytokinetics, Inc.	Verbindungen, zusammensetzungen und verfahren
WO2005046588A2 (en) *	2003-11-07	2005-05-26	Cytokinetics, Inc.	Compounds, compositions, and methods
US20050158320A1 (en) *	2003-11-12	2005-07-21	Nichols M. J.	Combinations for the treatment of proliferative diseases
US7501416B2 (en) *	2004-02-06	2009-03-10	Bristol-Myers Squibb Company	Quinoxaline compounds and methods of using them
CN1984912A (zh) *	2004-04-06	2007-06-20	希龙公司	有丝分裂驱动蛋白抑制剂
RU2007118523A (ru) *	2004-10-19	2008-11-27	Новартис Вэксинс Энд Диагностикс Инк. (Us)	Производные индола и бензимидазола

2004
- 2004-03-04 ES ES04717339T patent/ES2326647T3/es not_active Expired - Lifetime
- 2004-03-04 DK DK04717339T patent/DK1601673T3/da active
- 2004-03-04 WO PCT/SE2004/000304 patent/WO2004078758A1/en not_active Ceased
- 2004-03-04 MX MXPA05009577A patent/MXPA05009577A/es active IP Right Grant
- 2004-03-04 PL PL04717339T patent/PL1601673T3/pl unknown
- 2004-03-04 EP EP04717339A patent/EP1601673B1/de not_active Expired - Lifetime
- 2004-03-04 BR BRPI0408150-1A patent/BRPI0408150A/pt not_active IP Right Cessation
- 2004-03-04 SI SI200431186T patent/SI1601673T1/sl unknown
- 2004-03-04 CA CA2518224A patent/CA2518224C/en not_active Expired - Fee Related
- 2004-03-04 AU AU2004218080A patent/AU2004218080B2/en not_active Ceased
- 2004-03-04 PT PT04717339T patent/PT1601673E/pt unknown
- 2004-03-04 AT AT04717339T patent/ATE433448T1/de active
- 2004-03-04 JP JP2006507939A patent/JP3947758B2/ja not_active Expired - Fee Related
- 2004-03-04 US US10/548,138 patent/US20060270689A1/en not_active Abandoned
- 2004-03-04 NZ NZ542227A patent/NZ542227A/en not_active IP Right Cessation
- 2004-03-04 MY MYPI20040755A patent/MY141583A/en unknown
- 2004-03-04 KR KR1020057016722A patent/KR20050107784A/ko not_active Ceased
- 2004-03-04 DE DE602004021477T patent/DE602004021477D1/de not_active Expired - Lifetime
- 2004-03-05 TW TW093105906A patent/TW200510427A/zh unknown
- 2004-03-05 AR ARP040100701A patent/AR043487A1/es not_active Application Discontinuation
- 2004-04-03 UA UAA200509430A patent/UA81470C2/uk unknown
2005
- 2005-09-19 IS IS8036A patent/IS8036A/is unknown
- 2005-09-20 NO NO20054340A patent/NO20054340L/no unknown
2006
- 2006-07-25 JP JP2006201461A patent/JP2007063257A/ja active Pending
2009
- 2009-08-10 CY CY20091100845T patent/CY1109300T1/el unknown

Also Published As

Publication number	Publication date
US20060270689A1 (en)	2006-11-30
CA2518224A1 (en)	2004-09-16
CA2518224C (en)	2010-06-15
DE602004021477D1 (de)	2009-07-23
UA81470C2 (en)	2008-01-10
KR20050107784A (ko)	2005-11-15
JP2007063257A (ja)	2007-03-15
MXPA05009577A (es)	2005-12-12
WO2004078758A1 (en)	2004-09-16
AU2004218080B2 (en)	2008-01-03
DK1601673T3 (da)	2009-08-24
TW200510427A (en)	2005-03-16
HK1084390A1 (en)	2006-07-28
AR043487A1 (es)	2005-08-03
ES2326647T3 (es)	2009-10-16
MY141583A (en)	2010-05-14
JP3947758B2 (ja)	2007-07-25
PT1601673E (pt)	2009-07-29
IS8036A (is)	2005-09-19
NZ542227A (en)	2008-12-24
AU2004218080A1 (en)	2004-09-16
NO20054340L (no)	2005-09-26
BRPI0408150A (pt)	2006-03-21
EP1601673A1 (de)	2005-12-07
EP1601673B1 (de)	2009-06-10
PL1601673T3 (pl)	2009-10-30
JP2006519853A (ja)	2006-08-31
CY1109300T1 (el)	2014-07-02
SI1601673T1 (sl)	2009-10-31

Publication	Publication Date	Title
DE602004021904D1 (de)	2009-08-20	Gyraseinhibitoren und deren verwendungen
ATE433448T1 (de)	2009-06-15	Kondensierte heterocyclen und deren verwendungen
CY2018009I2 (el)	2018-06-27	Παραλλαγες ανοσοσφαιρινων και χρησεις αυτων
CY2016027I1 (el)	2017-06-28	Πολυμερικες ενωσεις πολυαλκυλενιου και χρησεις αυτων
DE60326611D1 (de)	2009-04-23	N und dergleichen
NL1025404A1 (nl)	2004-08-09	Pyrazolo-triazine verbindingen en gebruik daarvan.
DE60237726D1 (de)	2010-10-28	Roll-/Gleitelement und Rollvorrichtung
DE60321401D1 (de)	2008-07-10	Demodulationseinrichtung und demodulationsverfahren
DE502004009028D1 (de)	2009-04-02	Scheinwerfer und Scheinwerferelement
DE10397002A5 (de)	2013-05-08	Biosensor, Biosensorchip und Biosensoreinrichtung
DE60328206D1 (de)	2009-08-13	Scheibenwaschanlagendüse und scheibenwaschanlage
DE60316588D1 (de)	2007-11-08	Neue lactame und deren verwendungen
DE602004030044D1 (de)	2010-12-23	Bacillus thuringiensis und deren verwendungen
DE60331729D1 (de)	2010-04-29	Audiocodierungsverfahren und audiocodierungseinrichtung
DK1675852T3 (da)	2009-05-25	Heterocykliske 7-amino-alkylidenyl-quinoloner og -naphthyridoner
DE60333629D1 (de)	2010-09-16	Neue phospholipasen und deren verwendungen
ATE371653T1 (de)	2007-09-15	Benzoxazinderivate und deren verwendungen
DE60303480D1 (de)	2006-04-20	Sensorenanordnung und Halteklammer dafür
DE60304229D1 (de)	2006-05-18	Pinselabflacher und mit Pinselabflacher ausgerüstete Zeichenvorrichtung
EP1583528A4 (de)	2009-10-21	Nf-kb inhibitoren und ihre verwendungen
ATE446301T1 (de)	2009-11-15	Ausgewählte kondensierte heterocyclen und deren anwendung
DE602004032139D1 (de)	2011-05-19	Festes schmiermittel und gleitglied
EP1812055A4 (de)	2008-09-03	Chlamydien-antigene und ihre verwendungen
EP1687398A4 (de)	2008-09-10	Hiv-abhängige expressionskonstrukte und verwendungen dafür
ITMI20021373A1 (it)	2003-12-22	Mescole polimeriche e loro uso

Legal Events

Date	Code	Title	Description
2010-01-15	UEP	Publication of translation of european patent specification	Ref document number: 1601673 Country of ref document: EP

Date

Code

Title

Description

2010-01-15

UEP

Publication of translation of european patent specification

Ref document number: 1601673

Country of ref document: EP